RADIAN

Patients

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences.

Oncology

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.